- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06768112
Non-Invasive Vagus Nerve Stimulation Combine Postural Training in the Elderly
Adaptive Changes in Plasticity of Cerebrum and Cerebellum Following Innovative Postural
This three-year research proposal aims to enhance postural control in older adults using non-invasive vagus nerve stimulation (nVNS). The study will develop a new system integrating cerebellar EEG (ECeG), EEG, and ECG to assess how nVNS combined with postural training affects individuals with early-stage frontal degeneration.
In the first year, the focus will be on creating and validating the ECeG system to explore neural mechanisms of postural control. The second year will test the combined effects of ear-nVNS and dynamic posture training, examining how nVNS influences adrenal and hormone pathways. The final year will evaluate if ear-nVNS can further improve postural training with virtual feedback.
Overall, the project aims to advance fall prevention strategies for older adults by exploring the role of cerebellar function and innovative training methods.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan
- National Chen Kong University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: Participants aged 18-45 years (young adults) and 60-80 years (older adults).
- Vision should be within the normal range after visual correction.
- Lower limb strength requirement: Ability to climb stairs without holding onto anything, able to ascend 15 steps (a typical office building floor has approximately 15-20 steps).
- No history of falls in the past six months.
Exclusion Criteria:
Here is the translation of the provided text:
- Young adult participants: Exclude students from the Department of Physical Therapy, School of Medicine, and Institute of Behavioral Medicine at National Cheng Kung University.
- Uncontrolled cardiovascular diseases (e.g., hypertensive patients with resting systolic blood pressure exceeding 160 mmHg).
- Lower limb venous embolism, arterial calcification, and lymphatic issues.
- Diabetes, sickle cell anemia, coagulation disorders, dialysis patients, and those with conditions affecting walking, lower limb musculoskeletal function, and balance issues.
- No known psychiatric, neuromuscular, or degenerative neurological diseases.
- Hearing impairment or those using hearing aids.
- Dizziness caused by any lesions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
participants in this arm will conduct balance training without non-invasive vagal nerve stimulation.
|
Participants will be asked to stand on a soft-platform and hit on blaze-pod LED within 60 seconds.
The mini-mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.
|
|
Experimental: non-invasive vagal nerve stimulation
Participants will receive non-invasive vagal nerve stimulation and balance training
|
Participants will be asked to stand on a soft-platform and hit on blaze-pod LED within 60 seconds.
The mini-mental state examination (MMSE) or Folstein test is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment.
Using non-invasive vagus nerve stimulation at the ear to stimulate the adrenergic and serum hormone pathways, activating the frontal lobe system, sensory-motor nervous system, and cerebellum, to investigate the effects and neural mechanisms of dynamic posture training and learning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Performance
Time Frame: the first day, at the end of 5 days training
|
Analysis of cognitive tests including Stroop test and trail making test.
|
the first day, at the end of 5 days training
|
|
Brain activity
Time Frame: the first day, at the end of 5 days training
|
EEG Data Analysis
|
the first day, at the end of 5 days training
|
|
Kinematic Analysis of Upper and Lower Limb Dynamics
Time Frame: the first day, at the end of 5 days training
|
Participants are asked to stand with both feet on a soft-pad and try to maintain a stable posture with minimal body sway.
The center of pressure trajectory are taken to estimate behavioral and neurophysiological mechanisms.
The dual-task involves performing simultaneous tasks of tapping LED sensor lights in real-time while standing on the soft-pad force plate.
|
the first day, at the end of 5 days training
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini-Mental State Examination; MMSE
Time Frame: Before participating in the formal protocol, each subject must take the Mini-Mental State Examination to assess their cognitive level. This test is conducted only once per subject.
|
A total score of 30 points; a score below 24 indicates mild cognitive impairment.
Those with mild impairment will be evenly distributed into groups.
|
Before participating in the formal protocol, each subject must take the Mini-Mental State Examination to assess their cognitive level. This test is conducted only once per subject.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NSTC 113-2314-B-006 -080 -MY3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
Clinical Trials on balance training
-
University GhentCompletedFunctional Ankle InstabilityBelgium
-
Riphah International UniversityCompletedIntellectual ImpairmentPakistan
-
National Yang Ming UniversityCompletedChronic Ankle InstabilityTaiwan
-
RehaClinic AGCompleted
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Al-Quds UniversityCompletedStroke | Chronic Stroke | BalancePalestinian Territory, occupied
-
Montiha AzeemRecruitingChronic Ischemic StrokePakistan
-
Istanbul Medipol University HospitalCompletedCognitive RehabilitationTurkey
-
VA Office of Research and DevelopmentRecruiting
-
Tarsus UniversityCompleted